Brief: Telesis Bio Says Q4 Revenue Rose 191 Percent To $9.0 Million

Telesis Bio

09/01/2023 14:04

Jan 9 (Reuters) - Telesis Bio Inc  TBIO.O :
    * TELESIS BIO PRE-ANNOUNCES PRELIMINARY FOURTH QUARTER
FINANCIAL
RESULTS
    * TELESIS BIO INC Q4 REVENUE ROSE 191 PERCENT TO $9.0
MILLION
    * TELESIS BIO INC - AS OF DECEMBER 31, 2022, COMPANY HAD $41
MILLION IN CASH AND CASH EQUIVALENTS
    * TELESIS BIO - EXPECTS TO REPORT BIOXP REVENUE, CONSISTS OF
INSTRUMENTS AND KITS, FOR Q4 OF 2022 OF $3 MILLION COMPARED TO
$1.3 MILLION FOR SAME PERIOD IN 2021
    * TELESIS BIO INC - ACHIEVED FIRST TECHNICAL MILESTONE UNDER
ITS
2022 COLLABORATION AND LICENSING AGREEMENT WITH PFIZER TO
FURTHER DEVELOP SOLA

Source text for Eikon:  ID:nGNXbmbHvP 
Further company coverage:  TBIO.O 
 ((reuters.briefs@thomsonreuters.com;))